Search Results
Jul 17, 2026, 08:30 ET Galaxy secures landmark naming rights agreement with Texas Tech
other risks contained in filings we make with the Securities and Exchange Commission (the "SEC") from time to time, including in our Quarterly Report on Form 10-Q, available at
More news about: Galaxy Digital Inc.
Jul 17, 2026, 08:00 ET Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE), for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange
More news about: AbbVie
Jul 17, 2026, 08:00 ET Kimbell Royalty Partners, LP Announces $215.4 Million Drop Down Acquisition
benefits from and to integrate acquired assets, including the assets acquired in the Drop Down; and other risks described in Kimbell's Annual Report on Form 10-K and other filings with the SEC, available at the SEC's website at www.sec.gov. You are cautioned
More news about: Kimbell Royalty Partners, LP
Jul 17, 2026, 08:00 ET Lightspeed Commerce Advances Unified Commerce Vision with New AI, Payments, Fulfillment and Operations Innovations
recent Management's Discussion and Analysis of Financial Condition and Results of Operations, under "Risk Factors" in our most recent Annual Information Form, and in our other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available
More news about: Lightspeed Commerce Inc.
Jul 17, 2026, 08:00 ET Lightspeed Commerce Advances Unified Commerce Vision with New AI, Payments, Fulfillment and Operations Innovations
recent Management's Discussion and Analysis of Financial Condition and Results of Operations, under "Risk Factors" in our most recent Annual Information Form, and in our other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available
More news about: Lightspeed Commerce Inc.
Jul 17, 2026, 07:10 ET Solstice Advanced Materials Declares Dividend of $0.075 per Common Share
achieved. These forward-looking statements should be considered in light of the information included in this release, Solstice's 2025 Annual Report on Form 10-K, and other filings with the Securities and Exchange Commission. Any forward-looking plans described herein are not final and may be modified or
More news about: Solstice Advanced Materials US, Inc.
Jul 17, 2026, 07:00 ET REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants
Financial Condition and Results of Operations" sections of REGENXBIO's Annual Report on Form 10-K for the year ended December 31, 2025, and comparable "Risk Factors" sections of REGENXBIO's Quarterly Reports on Form 10-Q and other filings, which have been filed with the U.S. Securities and Exchange Commission
More news about: REGENXBIO Inc.
Jul 17, 2026, 06:58 ET Europe's congestion is costing fleets millions in wasted fuel, new Geotab data reveals
The findings form part of
More news about: Geotab Inc.
Jul 17, 2026, 06:16 ET Driive Launches Dot, a Virtual Scheduler Built on a Real Scheduling Brain, Not Just Another Voice AI Answering Service
Driive's drive-time-aware scheduling engine, so every call, form fill, and calendar request turns into an actual booked appointment, not just a message taken. LINCOLN,
More news about: Driive Inc.
Jul 17, 2026, 06:02 ET 13 Press Releases You Need to See This Week
indicates that treatment-resistant depression and other serious mental health conditions may involve a loss of synaptic plasticity, the brain's ability to form and strengthen connections in regions critical to mood regulation. AtaiBeckley's therapies are designed to restore synaptic connectivity and aim to
More news about: PR Newswire
Jul 17, 2026, 05:45 ET Leidos and DHL form alliance to strengthen the future of UK Defence logistics
implied by such forward-looking statements. These factors include, but are not limited to, the "Risk Factors" set forth in Leidos' Annual Report on Form 10-K for the fiscal year ended January 2, 2026, and other such filings that Leidos makes with the SEC from time to time. Readers are cautioned not to
More news about: Leidos
Jul 17, 2026, 05:00 ET Yum China Announces Disclosure under Hong Kong Stock Exchange Rules in Relation to a Possible Quarterly Dividend
Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q) for additional detail about factors that could affect our financial and other results.About Yum China Holdings,
More news about: Yum China Holdings, Inc.
Jul 17, 2026, 00:16 ET iQIYI Reports Strong H1 2026 Content Results, Cementing Its Position as China's Premier Streaming Destination
Dramas: A Commanding Lead Across MetricsiQIYI accounted for 10 of the 16 newly released long-form dramas that received an S+ rating from leading third-party data platform Enlightent across the industry in H1 2026. Furthermore,
More news about: iQIYI Inc.
Jul 16, 2026, 23:48 ET HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients while exploring the potential of NUZ-001
More news about: Neurizon Therapeutics Limited
Jul 16, 2026, 23:01 ET PrimeBOT gewinnt Gold und Silber beim A' Design Award 2026 - Eine neue Sprache für die persönliche Robotik
Nachbildungen hinaus und verzichtet auf synthetische Gesichter oder Hauttexturen. Stattdessen setzt es auf eine minimalistische Geometrie und eine geschlossene Form, die mechanische Strukturen verbirgt – und so die Distanz verringert, die Technologie oft schafft. Der Körper besteht aus Materialien, die sich warm
More news about: PrimeBOT
Jul 16, 2026, 22:58 ET PrimeBOT Wins Gold and Silver at A' Design Award 2026 -- A New Language for Personal Robotics
industry's fixation on human-like replication, rejecting synthetic faces or skin textures. Instead, it adopts a minimalist geometry and an enclosed form that conceals mechanical structures — reducing the distance technology often creates. The body uses warm-touch materials with soft curves that convey
More news about: PrimeBOT
Jul 16, 2026, 22:23 ET PrimeBOT Wins Gold and Silver at A' Design Award 2026 -- A New Language for Personal Robotics
industry's fixation on human-like replication, rejecting synthetic faces or skin textures. Instead, it adopts a minimalist geometry and an enclosed form that conceals mechanical structures — reducing the distance technology often creates. The body uses warm-touch materials with soft curves that convey
More news about: PrimeBOT
Jul 16, 2026, 20:49 ET Tampa General Hospital First in the Nation to Sign Nutrition Pledge
for anyone regardless of ability to pay; in fiscal year 2024, Tampa General provided a net community benefit of approximately $289.1 million in the form of healthcare for underinsured patients, community education and financial support to community health organizations in Tampa Bay. It is recognized
More news about: Tampa General Hospital
Jul 16, 2026, 20:34 ET Lemonade To Announce Second Quarter 2026 Financial Results
conflict in Israel and surrounding region.These and other important factors described under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed on February 25, 2026, and in our other subsequent filings with the SEC, could cause actual results
More news about: Lemonade, Inc.
Jul 16, 2026, 18:47 ET Stellus Private Credit BDC Announces $0.31 Third Quarter 2026 Regular Dividend, Payable Monthly in Increments of $0.1033 in July, August, and September 2026
under the Investment Company Act of 1940, as amended. The Company's investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation by investing primarily in private middle-market companies (typically those with $5.0 million to $50.0 million
More news about: Stellus Private Credit BDC
Jul 16, 2026, 18:47 ET Stellus Capital Investment Corporation Announces $0.25 Third Quarter 2026 Regular Dividend, Payable Monthly in Increments of $0.0833 in August, September, and October 2026
development company under the Investment Company Act of 1940. The Company's investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation by investing primarily in private middle-market companies (typically those with $5.0 million to $50.0 million
More news about: Stellus Capital Investment Corporation
Jul 16, 2026, 18:17 ET Are ATAI, FHB, PATK Obtaining Fair Deals for their Shareholders?
AtaiBeckley Inc. (NASDAQ: ATAI)'s sale to Eli Lilly and Company for $6.75 per share in cash, plus up to $2.50 per share in the form of a Contingent Value Right entitling the holder to additional cash payments upon achievement of specified development and regulatory milestones related
More news about: Halper Sadeh LLP
Jul 16, 2026, 17:00 ET DFIN to Announce Second-Quarter Results and Host Investor Conference Call on July 30, 2026
tables.DFIN's financial report for the second quarter will be released before the market opens on Thursday, July 30, 2026, via a filing with the SEC on Form 8-K and will also be posted on the Company's
More news about: Donnelley Financial LLC
Jul 16, 2026, 16:38 ET Simmons First National Corporation Reports Second Quarter Results
dividends. Additional information on factors that might affect the Company's financial results is included in the Company's Form 10-K for the year ended December 31, 2025, the Company's Form 10-Q for the quarter ended March 31, 2026, and other reports that the Company has filed with or furnished to the U.S.
More news about: Simmons First National Corporation
Jul 16, 2026, 16:30 ET Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe
Analysis of Financial Condition and Results of Operations" sections of Vanda's most recent Annual Report on Form 10-K, as updated by Vanda's subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the U.S. Securities and Exchange Commission, which are available at
More news about: Vanda Pharmaceuticals Inc.